The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy

导出原文传递

翻译打印收藏纠错

作者： Mangia, Anita ^[1] ; Caldarola, Lucia ^[2] ; Dell'Endice, Stefania ^[3] ; Scarpi, Emanuela ^[4] ; Saragoni, Luca ^[5] ; Monti, Manlio ^[6] ; Santini, Daniele ; Brunetti, Oronzo ; Simone, Giovanni ; Silvestris, Nicola

作者单位： IRCCS Meldola, Ist Sci Romagnolo Studio & Cura Tumori IRST, Dept Med Oncol, Meldola, FC, Italy ^[1] Morgagni Pierantoni Hosp, Pathol Unit, Forli, Italy ^[2] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Funct Biomorphol Lab, Bari, Italy ^[3] Univ Campus Biomed, Med Oncol Unit, Rome, Italy ^[4] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Pathol Dept, Bari, Italy ^[5] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Med Oncol Unit, Bari, Italy ^[6]

关键词 chemotherapy gastric cancer immunohistochemistry multi-drug resistance NHERF1/EBP50 predictive factor

发布时间 2015-10-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交